Moderna (Nasdaq:MRNA) announced today that it appointed Jorge Gomez as its new chief financial officer.
Gomez resigned as CFO of Dentsply Sirona (Nasdaq:XRAY), effective May 6, to assume the same role at Cambridge, Massachusetts-based Moderna. He will join effective May 9.
Dentsply Sirona said in a news release that it is initiating a search process to identify its next CFO.
“We thank Jorge for his many contributions since joining Dentsply Sirona in 2019, including strengthening the Finance and IT organizations and enhancing our ESG initiative,” Dentsply Sirona CEO Don Casey said.
Gomez has served as EVP and CFO at Dentsply since August 2019. He also spent 13 years at Cardinal Health, with his most recent role there also being CFO.
“I am pleased to welcome Jorge to Moderna as our chief financial officer and as a member of the Executive Committee,” Moderna CEO Stéphane Bancel said in a release. “As we grow and scale the company globally, Jorge’s experience leading the financial functions of multinational healthcare companies will be an asset to our team. Jorge’s passion for sustainability and ESG aligns closely with Moderna’s vision to make corporate responsibility a critical part of who we are and what we do. I look forward to working with Jorge as we continue to deliver on our strategic priorities to ultimately impact human health with mRNA medicines.”
Gomez will serve on Moderna’s executive committee and report to Bancel. Moderna’s current CFO, David Meline, decided to retire but will remain with the company as a consultant to ensure a smooth transition.
“It is a privilege for me to join an organization that is focused on developing transformative medicines to address major public healthcare challenges worldwide,” Gomez said. “I look forward to working with the team on this great mission.”
Filed Under: Drug Discovery, Drug Discovery and Development
